S
ISSUER//CIK 0000911326
SYNAGEVA BIOPHARMA CORP
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A8.3 KBSYNAGEVA BIOPHARMA CORPFeb 12, 5:44 PM ET·0000858744-16-000037
- 36.9 KBSYNAGEVA BIOPHARMA CORPJun 29, 5:30 PM ET·0001571049-15-005382
- SC 13D/A116.9 KBSYNAGEVA BIOPHARMA CORPJun 24, 6:00 AM ET·0001144204-15-038778
- 45.3 KBSYNAGEVA BIOPHARMA CORPJun 23, 5:43 PM ET·0001144204-15-038750
- 490.0 KBSYNAGEVA BIOPHARMA CORPJun 23, 5:42 PM ET·0001144204-15-038749
- 430.4 KBSYNAGEVA BIOPHARMA CORPJun 23, 10:41 AM ET·0001209191-15-055581
- 429.0 KBSYNAGEVA BIOPHARMA CORPJun 23, 10:38 AM ET·0001209191-15-055580
- 424.1 KBSYNAGEVA BIOPHARMA CORPJun 23, 10:37 AM ET·0001209191-15-055579
- 427.3 KBSYNAGEVA BIOPHARMA CORPJun 23, 10:37 AM ET·0001209191-15-055578
- 415.8 KBSYNAGEVA BIOPHARMA CORPJun 23, 10:35 AM ET·0001209191-15-055577
Insiders
10- 14159, L.P.Director, 10% Owner
- 667, L.P.Director, 10% Owner
- AKKARAJU SRINIVASDirector
- ALEXION PHARMACEUTICALS, INC.10% Owner
- Alrutz Michael AlbertGeneral Counsel
- Baker Biotech Capital (GP), LLCDirector, 10% Owner
- Baker Biotech Capital II (GP), LLCDirector, 10% Owner
- Baker Bros. Advisors (GP) LLCDirector, 10% Owner
- BAKER BROS. ADVISORS LPDirector, 10% Owner
- Baker Bros. Capital (GP), LLCDirector, 10% Owner
Tickers
No tickers on record
Addresses
business
33 HAYDEN AVE.
LEXINGTON, MA, 02421
mailing
33 HAYDEN AVE.
LEXINGTON, MA, 02421
Former Names
- TRIMERIS INC2011-10-13